OBJECTIVE: Current guidelines for office blood pressure (BP) measurement recommend mercury devices, both arms measurement in the initial assessment and at least duplicate measurements at follow-up visits. This study presents the design and a pilot application study of an automated device that fulfils American, European, and International guidelines for office BP measurement. DESIGN AND FUNCTIONS: The Microlife WatchBP Office is a professional electronic mercury-free device with three function modes designed for: (a) initial assessment: triplicate automated simultaneous oscillometric both arms measurement at 60-s intervals and when there is a consistent interarm difference more than 20 mmHg systolic and/or more than 10 mmHg diastolic, the arm with the higher BP is indicated. (b) Follow-up assessment: triplicate automated oscillometric single arm measurements at 60-s intervals and their average is displayed. (c) Auscultatory measurement: by an observer using a stethoscope and a digital countdown BP display for patients with arrhythmias and other individuals in whom the oscillometric measurement is not accurate. PILOT APPLICATION STUDY: The 'initial assessment' mode was applied by three physicians in 63 patients (189 readings). Average interarm systolic BP difference was 0.04+/-5.1 mmHg and diastolic 0.4+/-3.2 mmHg. A value more than 10 mmHg interarm difference in nine systolic BP readings (5%) and three (2%) diastolic. No patient had a consistent interarm difference more than 10 mmHg in all three or two of the three readings. CONCLUSION: The Microlife WatchBP Office professional device fulfils current international requirements for office BP measurement and seems to overcome several limitations of this method when applied in clinical practice.
OBJECTIVE: Current guidelines for office blood pressure (BP) measurement recommend mercury devices, both arms measurement in the initial assessment and at least duplicate measurements at follow-up visits. This study presents the design and a pilot application study of an automated device that fulfils American, European, and International guidelines for office BP measurement. DESIGN AND FUNCTIONS: The Microlife WatchBP Office is a professional electronic mercury-free device with three function modes designed for: (a) initial assessment: triplicate automated simultaneous oscillometric both arms measurement at 60-s intervals and when there is a consistent interarm difference more than 20 mmHg systolic and/or more than 10 mmHg diastolic, the arm with the higher BP is indicated. (b) Follow-up assessment: triplicate automated oscillometric single arm measurements at 60-s intervals and their average is displayed. (c) Auscultatory measurement: by an observer using a stethoscope and a digital countdown BP display for patients with arrhythmias and other individuals in whom the oscillometric measurement is not accurate. PILOT APPLICATION STUDY: The 'initial assessment' mode was applied by three physicians in 63 patients (189 readings). Average interarm systolic BP difference was 0.04+/-5.1 mmHg and diastolic 0.4+/-3.2 mmHg. A value more than 10 mmHg interarm difference in nine systolic BP readings (5%) and three (2%) diastolic. No patient had a consistent interarm difference more than 10 mmHg in all three or two of the three readings. CONCLUSION: The Microlife WatchBP Office professional device fulfils current international requirements for office BP measurement and seems to overcome several limitations of this method when applied in clinical practice.
Authors: Jang Young Kim; Eung Ju Kim; June Namgung; Byung-Ryul Cho; Chang-Wook Nam; Young-Kwon Kim; Jeong Bae Park Journal: Hypertens Res Date: 2016-12-22 Impact factor: 3.872
Authors: John Doane; Michael Flynn; Marcus Archibald; Dominick Ramirez; Molly B Conroy; Barry Stults Journal: J Clin Hypertens (Greenwich) Date: 2020-03-09 Impact factor: 3.738
Authors: Gurpreet S Wander; Sinead T J McDonagh; M Srinivasa Rao; R Alagesan; J C Mohan; Ajit Bhagwat; A K Pancholia; M Viswanathan; Manoj Bhavrilal Chopda; A Purnanand; P L N Kapardhi; Arun R Vadavi; R Selvaraj; Pankaj Aneja; Suhas Hardas; Neil Bordoloi; N Sivakadaksham; Nilesh Goswami; Christopher E Clark; Willem J Verberk Journal: J Clin Hypertens (Greenwich) Date: 2022-07-10 Impact factor: 2.885